Healthy aging begins with understanding changes in health, not a promise to reverse time. A clinical assessment can consider symptoms, medical history, medications, sleep, nutrition and activity before discussing any treatment.
New or persistent symptoms should not automatically be attributed to aging or a presumed hormone deficiency. The next step may be further evaluation, preventive care, rehabilitation or an established treatment for a diagnosed condition.
Peptide research is one area where laboratory findings, product marketing and clinical evidence are often confused. Ipamorelin, sermorelin and tesamorelin have different approval histories and should not be grouped together as approved anti-aging therapies. Our peptide guide explains those distinctions, along with CJC-1295, BPC-157 and GHK-Cu, including evidence limitations and important risks. It is educational information and does not offer these products for sale or prescription.